About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
F3tm1Dco
targeted mutation 1, Desire Collen
MGI:2178434
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
F3tm1Dco/F3tm1Dco Not Specified MGI:3687345
cx2
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0
B6.Cg-F3tm1Dco Tg(F3)1Nmk MGI:4822465
cx3
F3tm1Dco/F3tm1Dco
Thbdtm2Rdr/Thbdtm2Rdr
Tg(F3)1Nmk/0
involves: 129/Sv * 129S2/SvPas * BALB/c * C57BL/6 MGI:3687574
cx4
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0
involves: 129/Sv * BALB/c * C57BL/6 MGI:2654490
cx5
F3tm1Dco/F3tm1Dco
Thbdtm2Rdr/Thbdtm2Rdr
involves: 129S2/SvPas * C57BL/6 MGI:2653104
cx6
F3tm1Dco/F3tm1Dco
Procrtm1Cte/Procrtm1Cte
Tg(F3)1Nmk/0
involves: 129S7/SvEvBrd * BALB/c * Black Swiss * C57BL/6 * FVB/N MGI:3702952
cx7
F3tm1Dco/F3tm1Dco
Procrtm1Cte/Procrtm1Cte
involves: 129S7/SvEvBrd * BALB/c * Black Swiss * C57BL/6 * FVB/N MGI:3702956
cx8
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/?
involves: BALB/c * C57BL/6 MGI:3826856


Genotype
MGI:3687345
hm1
Allelic
Composition
F3tm1Dco/F3tm1Dco
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes die in utero between E9.5 and E10.5
• a small number (1.3%) survive beyond E10.5 but die at ~E13.5-E14.5 of unknown causes

embryo
• at E9.5, ~33.3% of mutant embryos are normal; however, nearly all embryos appear abnormal at E10.5, with extensive necrosis both in the embryo proper and yolk sac
• at E9.5, severely affected homozygotes display extensive embryonic tissue necrosis
• at E9.5, homozygotes exhibit wasting of variable onset and penetrance
• ensuing necrosis appears to result from ischemia secondary to defective vitello-embryonic circulation and wasting
• severely affected homozygotes display extensive embryonic tissue necrosis
• at E9.5, ~66.6% of homozygotes display abnormal yolk sac vessels with strands of acellular material connecting endoderm and mesothelium
• vascular yolk-sac defects precede embryo wasting and necrosis and are noted in embryos still embedded in their decidua
• at E9.5, fragility of mutant vitelline vessels is associated with lack of mesenchymal cell/pericyte accumulation and function, reduced extracellular matrix, and hypoplasia of the muscular wall of primitive vessels; in contrast, endoderm, endothelial and mesothelial cells appear normal
• at E9.5, ~66.6% of mutant yolk sacs lack large vitelline vessels
• at E9.5, ~66.6% of homozygotes exhibit an irregular vascular plexus of enlarged capillaries that appear to fuse with each other
• in vitro, cultured E9.5 mutant embryos exhibit a confluent disorganized vascular plexus ("blood lakes") with no large vitelline vessels
• at E9.5, no blood flow is observed in mutant yolk sacs
• in vitro, cultured E9.5 mutant embryos exhibit pale yolk sacs

cardiovascular system
• at E9.5, ~66.6% of homozygotes display abnormal yolk sac vessels with strands of acellular material connecting endoderm and mesothelium
• vascular yolk-sac defects precede embryo wasting and necrosis and are noted in embryos still embedded in their decidua
• at E9.5, fragility of mutant vitelline vessels is associated with lack of mesenchymal cell/pericyte accumulation and function, reduced extracellular matrix, and hypoplasia of the muscular wall of primitive vessels; in contrast, endoderm, endothelial and mesothelial cells appear normal
• at E9.5, ~66.6% of mutant yolk sacs lack large vitelline vessels
• at E9.5, ~66.6% of homozygotes exhibit an irregular vascular plexus of enlarged capillaries that appear to fuse with each other
• in vitro, cultured E9.5 mutant embryos exhibit a confluent disorganized vascular plexus ("blood lakes") with no large vitelline vessels
• in vitro, severely affected E9.5 mutant embryos exhibit an enlarged pericardial sac and blood in the extracoelomic cavity

integument
• at E9.5, severely affected homozygotes appear pale and anemic due to extravasation of embryonic blood cells in the extracoelomic cavity

cellular
• at E9.5, homozygotes exhibit wasting of variable onset and penetrance
• ensuing necrosis appears to result from ischemia secondary to defective vitello-embryonic circulation and wasting
• severely affected homozygotes display extensive embryonic tissue necrosis




Genotype
MGI:4822465
cx2
Allelic
Composition
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0
Genetic
Background
B6.Cg-F3tm1Dco Tg(F3)1Nmk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Tg(F3)1Nmk mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• when challenged with lipopolysaccharide (LPS), mutants exhibit prolonged survival and decreased mortality compared to controls

homeostasis/metabolism
• LPS induced formation of thrombin-antithrombin-III complexes is reduced compared to controls, indicating that activation of coagulation is attenuated
• IL-6 expression is reduced at 8-12 hours after LPS challenge

immune system
• IL-6 expression is reduced at 8-12 hours after LPS challenge
• when challenged with lipopolysaccharide (LPS), mutants exhibit prolonged survival and decreased mortality compared to controls




Genotype
MGI:3687574
cx3
Allelic
Composition
F3tm1Dco/F3tm1Dco
Thbdtm2Rdr/Thbdtm2Rdr
Tg(F3)1Nmk/0
Genetic
Background
involves: 129/Sv * 129S2/SvPas * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Tg(F3)1Nmk mutation (0 available)
Thbdtm2Rdr mutation (0 available); any Thbd mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• mutant embryos develop normally beyond E10.5 and are viable to birth

embryo
• at E10.5, mutant embryos exhibit bleeding in the placental labyrinth, not caused by thrombomodulin deficiency but characteristic of embryos with low F3 activity

cardiovascular system
• at E10.5, mutant embryos exhibit bleeding in the placental labyrinth, not caused by thrombomodulin deficiency but characteristic of embryos with low F3 activity




Genotype
MGI:2654490
cx4
Allelic
Composition
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0
Genetic
Background
involves: 129/Sv * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Tg(F3)1Nmk mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• unlike homozygous null embryos, rescued mice carrying the human minigene and expressing low (<1%) of activity survive embryonic lethality and display normal development and fertility, with no signs of a bleeding diathesis and normal viability up to 7 months of age




Genotype
MGI:2653104
cx5
Allelic
Composition
F3tm1Dco/F3tm1Dco
Thbdtm2Rdr/Thbdtm2Rdr
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Thbdtm2Rdr mutation (0 available); any Thbd mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• unlike Thbdtm2Rdr homozygotes which are completely resorbed by E9.5, double homozygotes develop normally until E9.5 but become necrotic by E10.5 due to defective yolk sac vasculature

embryo
• by E10.5, double homozygotes display defective vitelline vasculature with free blood pools in the yolk sac cavity
• by E10.5, double mutant yolk sacs lack blood-filled larger vitelline vessels

cardiovascular system
• by E10.5, double homozygotes display defective vitelline vasculature with free blood pools in the yolk sac cavity
• by E10.5, double mutant yolk sacs lack blood-filled larger vitelline vessels
• by E10.5, double homozygotes exhibit an enlarged pericardial cavity, similar to F3tm1Dco homozygotes




Genotype
MGI:3702952
cx6
Allelic
Composition
F3tm1Dco/F3tm1Dco
Procrtm1Cte/Procrtm1Cte
Tg(F3)1Nmk/0
Genetic
Background
involves: 129S7/SvEvBrd * BALB/c * Black Swiss * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Procrtm1Cte mutation (0 available); any Procr mutation (15 available)
Tg(F3)1Nmk mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• mice are born at expected frequency and survive at least 8 months




Genotype
MGI:3702956
cx7
Allelic
Composition
F3tm1Dco/F3tm1Dco
Procrtm1Cte/Procrtm1Cte
Genetic
Background
involves: 129S7/SvEvBrd * BALB/c * Black Swiss * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Procrtm1Cte mutation (0 available); any Procr mutation (15 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no embryos with this genotype are found at birth




Genotype
MGI:3826856
cx8
Allelic
Composition
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/?
Genetic
Background
involves: BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
F3tm1Dco mutation (0 available); any F3 mutation (24 available)
Tg(F3)1Nmk mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• hemosiderin deposition and fibrosis after 6 months of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory